MEIP - MEI Pharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5125.47M
Enterprise Value 343.18M
Trailing P/E N/A
Forward P/E 1-2.29
PEG Ratio (5 yr expected) 119.00
Price/Sales (ttm)28.96
Price/Book (mrq)3.31
Enterprise Value/Revenue 39.97
Enterprise Value/EBITDA 6-1.03

Trading Information

Stock Price History

Beta (3Y Monthly) 0.88
52-Week Change 3-59.47%
S&P500 52-Week Change 30.90%
52 Week High 34.8000
52 Week Low 31.4400
50-Day Moving Average 31.8531
200-Day Moving Average 32.6604

Share Statistics

Avg Vol (3 month) 3477.87k
Avg Vol (10 day) 3240.13k
Shares Outstanding 537.32M
Float 50.47M
% Held by Insiders 10.78%
% Held by Institutions 158.14%
Shares Short (Jul 31, 2019) 4686.25k
Short Ratio (Jul 31, 2019) 41.48
Short % of Float (Jul 31, 2019) 40.97%
Short % of Shares Outstanding (Jul 31, 2019) 40.96%
Shares Short (prior month Jun 28, 2019) 41.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 26/1
Last Split Date 3Dec 19, 2012

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-968.61%

Management Effectiveness

Return on Assets (ttm)-42.54%
Return on Equity (ttm)-110.53%

Income Statement

Revenue (ttm)4.33M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)188.50%
Gross Profit (ttm)-1.76M
EBITDA -41.91M
Net Income Avi to Common (ttm)-39.12M
Diluted EPS (ttm)-0.9380
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)82.29M
Total Cash Per Share (mrq)1.15
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)7.21
Book Value Per Share (mrq)0.53

Cash Flow Statement

Operating Cash Flow (ttm)-25.11M
Levered Free Cash Flow (ttm)-15.44M